Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Transporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07038356
What this trial is testing

Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure (ADHF)
Christian Schulze 536
Post-approval studies (Phase 4)UnknownNCT02719756
What this trial is testing

Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2

Who this might be right for
Diabetes MellitusHypoglycemic Episodes
Research Clinical Centre of the Russian Railways, JSC 100
Large-scale testing (Phase 3)UnknownNCT05776043
What this trial is testing

Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
Medical University of Warsaw 1,364
Large-scale testing (Phase 3)WithdrawnNCT04764097
What this trial is testing

Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease

Who this might be right for
Cardiovascular DiseasesEnd Stage Renal Disease
Tan Tock Seng Hospital
Large-scale testing (Phase 3)Study completedNCT06109311
What this trial is testing

Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 546
Not applicableStudy completedNCT05943899
What this trial is testing

Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis

Who this might be right for
Type2diabetes
Diabetes Foundation, India 60
Post-approval studies (Phase 4)UnknownNCT03573102
What this trial is testing

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Who this might be right for
Diabetic Nephropathies
Nahla H Tohami 60
Not applicableLooking for participantsNCT06932081
What this trial is testing

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Who this might be right for
Adult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right Ventricle+5 more
Leiden University Medical Center 400
Post-approval studies (Phase 4)Temporarily pausedNCT05435235
What this trial is testing

Dapagliflozin in the Prevention of Post-Coronary Angioplasty Acute Kidney Injury

Who this might be right for
Acute Kidney InjuryPercutaneous Coronary Intervention
Albert Einstein Healthcare Network 250
Not applicableUnknownNCT05897489
What this trial is testing

SGLT2 for Heart Failure in CHD Patients

Who this might be right for
Heart Failure
Centre Hospitalier Universitaire de Nice 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07108985
What this trial is testing

Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2HyperglycemiaInsulin Resistance
Yonsei University 100
Not applicableStudy completedNCT02578563
What this trial is testing

Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in Singapore

Who this might be right for
Diabetes Mellitus
AstraZeneca 201
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Post-approval studies (Phase 4)Active Not RecruitingNCT06933355
What this trial is testing

Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension

Who this might be right for
Kidney Transplantation RecipientsMagnetic Resonance Imaging (MRI)Sodium-Glucose Transporter 2 Inhibitors+3 more
Odense University Hospital 8
Not applicableStudy completedNCT06370247
What this trial is testing

First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy

Who this might be right for
SGLT2 Inhibitors, First Time UseType2 DiabetesFasting in Ramadan
Sohag University 60
Post-approval studies (Phase 4)Study completedNCT05233163
What this trial is testing

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
Columbia University 15
Not applicableUnknownNCT05686616
What this trial is testing

SGLT2 Inhibitor for Severe Tricuspid Regurgitation

Who this might be right for
Tricuspid Regurgitation
Samsung Medical Center 72
Post-approval studies (Phase 4)Study completedNCT05748925
What this trial is testing

Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients

Who this might be right for
SLELupus NephritisSGLT2 Inhibitors
Mansoura University 84
Testing effectiveness (Phase 2)Study completedNCT02529449
What this trial is testing

Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Astellas Pharma Inc 43
Post-approval studies (Phase 4)Study completedNCT05704088
What this trial is testing

SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients

Who this might be right for
SGLT2 INHIBITORSLupus NephritisBMD
Mansoura University 100
Next Page